Page last updated: 2024-12-07

2-o-methylpyrogallol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-O-methylpyrogallol is a naturally occurring phenolic compound found in various plants, including Rhus verniciflua and Pistacia lentiscus. It exhibits antioxidant and anti-inflammatory properties. Research suggests its potential as a therapeutic agent for conditions like neurodegenerative diseases and cancer. The compound is often synthesized via methylation of pyrogallol, and its biological activity is attributed to its ability to scavenge free radicals and inhibit the production of inflammatory mediators. Studies investigating 2-O-methylpyrogallol explore its potential therapeutic applications and its role in plant defense mechanisms.'

2-O-methylpyrogallol: metabolite of gallic acid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121805
CHEMBL ID485792
CHEBI ID165231
SCHEMBL ID69297
MeSH IDM0287842

Synonyms (51)

Synonym
2-methoxyresorcinol
1,3-benzenediol, 2-methoxy-
DIVK1C_006843
SDCCGMLS-0066488.P001
SPECTRUM_000398
SPECTRUM5_000160
BSPBIO_002799
NCGC00095532-01
KBIO2_000878
KBIOGR_002060
KBIO2_003446
KBIO2_006014
KBIOSS_000878
KBIO1_001787
KBIO3_002299
SPECTRUM3_001180
SPECTRUM4_001560
SPECTRUM2_001836
SPBIO_001911 ,
SPECPLUS_000747
SPECTRUM211066
NCGC00095532-02
AKOS000282505
CHEBI:165231
29267-67-2
2-methoxybenzene-1,3-diol
2-o-methylpyrogallol
CHEMBL485792
pyrogallol-2-methyl ether
1,3-dihydroxy-2-methoxybenzene
2-methoxy-1,3-benzenediol
CCG-38464
3uw7031f6p ,
einecs 249-542-1
unii-3uw7031f6p
FT-0638846
resorcinol, 2-methoxy-
SCHEMBL69297
1,3-dihydroxy-2-methoxybenzene,2-methoxyresorcinol
2-methoxy-1,3-benzenediol #
DTXSID60183520
mfcd00017299
sr-05000002376
SR-05000002376-1
J-017464
2-methoxyresorcino
BRD-K20559594-001-03-2
2,6-dihydroxyanisole
Q27258054
CS-0450653
PD002133
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency4.10950.000811.382244.6684AID686979
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID377909Antioxidant activity assessed as DPPH free radical scavenging activity2000Journal of natural products, Oct, Volume: 63, Issue:10
Urinary metabolites of gallic acid in rats and their radical-scavenging effects on 1,1-diphenyl-2-picrylhydrazyl radical.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]